Related Experiment Video
Updated: Jun 30, 2026
07:35
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
Published on: April 25, 2014
Extensively drug-resistant tuberculosis.
Miguel G Madariaga1, Umesh G Lalloo, Susan Swindells
1Section of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE 68198-8106, USA. mmadariaga@unmc.edu
The American Journal of Medicine
|October 1, 2008
Summary
Extensively drug-resistant tuberculosis (XDR-TB) is a growing global threat requiring rapid diagnosis and challenging treatment. Early detection and improved public health infrastructure are crucial for managing this severe form of tuberculosis.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Extensively drug-resistant tuberculosis (XDR-TB) is defined by resistance to key anti-TB drugs.
- XDR-TB, initially identified in South Africa, is now a global health concern, with cases reported worldwide.
- Inadequate treatment and public health failures are primary drivers of XDR-TB emergence.
Purpose of the Study:
- To highlight the global threat of extensively drug-resistant tuberculosis.
- To emphasize the need for improved diagnostic capabilities and laboratory networks.
- To discuss the challenges in treating XDR-TB and the importance of infection control.
Main Methods:
- This study is a review of the current understanding of XDR-TB.
- It synthesizes information on the definition, emergence, diagnosis, and treatment of XDR-TB.
- It discusses the implications for public health and patient management.
Main Results:
- XDR-TB poses a significant global challenge, necessitating urgent attention.
- Accurate and rapid diagnostic tests are essential for identifying active cases.
- Effective treatment regimens are complex and may involve surgery.
Conclusions:
- Strengthening diagnostic networks and developing faster tests are critical for combating XDR-TB.
- Managing XDR-TB requires a multi-faceted approach, including robust treatment strategies and stringent infection control.
- Addressing underlying public health infrastructure issues is vital to curb the spread of drug-resistant tuberculosis.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...